Top Markets
#1 DeFiChain DeFiChain +1,198.24%
#2 Superfortune Superfortune +102.78%
#3 V.I.T.R.I.O.L. Network V.I.T.R.I.O.L. Network +82.96%
#4 The Black Bull The Black Bull +80.59%
#5 Metaplex Metaplex +79.35%
#6 TokenOS AI TokenOS AI +59.62%
#7 Nexus Nexus +56.52%
#8 Alien Worlds Alien Worlds +55.53%
#9 Magma Finance Magma Finance +47.14%
#10 Hamster Kombat Hamster Kombat +36.70%
Coin of the day
DeFiChain DeFiChain
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Virbac SA Virbac SA

Virbac SA

VIRP
Rang in Aktien #3592
Virbac SA manufactures and sells a range of products and services for companion... Virbac SA manufactures and sells a range of products and services for companion and food-producing animals in France, Europe, Latin America, North America, the Asia Pacific, the Middle East, and Africa. The company offers a range of vaccines, dental hygiene, reproduction, dermatology, parasiticides, diagnostic, antibiotics, and aquaculture products; and veterinary medicines for anesthesia, geriatrics, behavior, and injectable micronutrients, as well as petfood and electronic identification. It serves veterinarians, farmers, and pet owners. Virbac SA was founded in 1968 and is headquartered in Carros, France.
Aktienkurs
$393.80
Marktkapitalisierung
$3.30B
Veränderung (1 Tag)
0.15%
Veränderung (1 Jahr)
4.67%
Land
FR
Handel Virbac SA (VIRP)

Kategorie

Healthcare
Aktien-Split-Historie für Virbac SA (VIRP)
Die Aktie Virbac SA (Symbol: VIRP) durchlief insgesamt 1 Aktiensplits.
Der letzte Aktiensplit fand am Jul 30, 2002 statt.
Eine VIRP-Aktie, die vor dem Jul 30, 2002 gekauft wurde, entspricht heute 4 VIRP-Aktien.
Liste der Aktiensplits
Jahr Aktien-Split Multiplikator Kumulierter Multiplikator
2002-07-30 4:1 x4 x4
Aktiensplits ähnlicher Unternehmen oder Wettbewerber
Unternehmen Anzahl der Aktiensplits Kumulierter Multiplikator Land
Eli Lilly Eli Lilly
Eli Lilly
LLY.US
 4 x15
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
 7 x432
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
 0 -
US
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
 7 x226
US
Novartis AG Novartis AG
Novartis AG
NVS.US
 2 x2
CH